Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex

Publisher： John Wiley & Sons Inc

E-ISSN： 1528-1167|56|7|1088-1097

ISSN： 0013-9580

Source： EPILEPSIA, Vol.56, Iss.7, 2015-07, pp. : 1088-1097

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 4, 2015-04 ,pp. : 368-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tuberous Sclerosis Complex: Genetic Aspects

By  

THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 11, 1992-11 ,pp. : 914-919

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Tuberous Sclerosis Complex, A Prototype of Hamartiosis and Hamartomatosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 19, Iss. 11, 1992-11 ,pp. : 892-896

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severity of manifestations in tuberous sclerosis complex in relation to genotype

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 1025-1029

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tuberous Sclerosis

By  

Pediatric Neurosurgery, Vol. 37, Iss. 5, 2002-10 ,pp. : 276-277

Karger

Access to resources Recommend Favorite